Sort
130,381 grants matching “hiv”
QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE
$1,809,037Elizabeth Wonderlich · Southern Research Institute · N01 · FY2020 · AI
Drug Design Cycle targeting HIV Protease Drug Resistance
$1,808,848Arthur J. Olson · Scripps Research Institute, The · P01 · FY2006 · GM
Chronic HIV infection and Aging in NeuroAIDS (CHAIN) Center
$1,808,624Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2011 · MH
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,808,268Robert Cooke · Heptares Therapeutics, Ltd · R01 · FY2017 · DA
Antibody Neutralization Mechanisms
$1,808,122Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Pathogenesis and Treatment of HIV Infection
$1,808,119Henry C Lane · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
$1,807,527John Kinuthia · Kenyatta National Hospital · RF1 · FY2025 · MH
HIV Vaccine Design and Dev. Teams for Preventation and Treatment
$1,807,525 · N01 · FY2008 · AI
Center for AIDS Prevention Studies
$1,806,675Stephen F Morin · University Of California, San Francisco · P30 · FY2011 · MH
Preclinical Development Services for AIDS Therapeutics
$1,806,515Jon Mirsalis · Sri International · N01 · FY2018 · AI
UAB Center for AIDS Research (CFAR)
$1,806,490Renee A. Heffron · University Of Alabama At Birmingham · P30 · FY2025 · AI
DNA Vaccines
$1,806,442George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Novel approaches for vaccine design
$1,805,982Michel C Nussenzweig · Rockefeller University · P01 · FY2011 · AI
CORE SURVEILLANCE AND HIV INCIDENCE SURVEILLANCE
$1,805,694Ling Hsu · San Francisco Department Of Public Health · U62 · FY2008 · PS
HIV VACCINE CLINICAL TRIALS UNIT
$1,805,507University Of Rochester · U01 · FY2002 · AI
Lymphocyte Dynamics
$1,805,388William E. Paul · Niaid Extramural Activities · Z01 · FY2007 · AI
Novel approaches for vaccine design
$1,805,259Michel C Nussenzweig · Rockefeller University · P01 · FY2012 · AI
Immunology and Virology of Acute HIV Infection
$1,805,181University Of Washington · P01 · FY2004 · AI
Descriptive Studies and Record Linkage
$1,804,510William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive Antibody (HCA) through Clinical Trials
$1,804,492Deborah J Anderson · Boston University Medical Campus · P50 · FY2023 · HD
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE
$1,804,298Titus Syengo · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2013 · PS
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
$1,803,929Joel Palefsky · University Of California, San Francisco · U54 · FY2023 · CA
PROFICIENCY TESTING FOR HIV RAPID TESTS, BIOLOGICAL SAFETY CABINET CERTIFICATION
$1,803,877Fausta Mosha · African Field Epidemiology Network, Ltd · U2G · FY2014 · PS
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs
$1,803,472Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2020 · AI
Neuropathogenesis of Retroviral Infections
$1,803,352Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS